🇺🇸 Mektovi in United States

Mektovi (binimetinib) regulatory status in United States.

Marketing authorisation

FDA

  • Application: ANDA217509
  • Marketing authorisation holder: TEVA PHARMACEUTICALS USA, INC.
  • Local brand name: BINIMETINIB
  • Indication: TABLET
  • Status: approved

Read official source →

Mektovi in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Mektovi approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Mektovi in United States?

TEVA PHARMACEUTICALS USA, INC. holds the US marketing authorisation.